These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 23257155)

  • 21. [Screening of cancer of the most frequent localizations].
    Belialova NS; Belialov FI
    Klin Med (Mosk); 2005; 83(10):4-9. PubMed ID: 16320836
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening for prostate cancer - will we ever know?
    Adolfsson J
    Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
    [No Abstract]   [Full Text] [Related]  

  • 23. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.
    Andriole GL; Reding D; Hayes RB; Prorok PC; Gohagan JK;
    Urol Oncol; 2004; 22(4):358-61. PubMed ID: 15283897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"?
    Barry MJ; Albertsen PC
    Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323
    [No Abstract]   [Full Text] [Related]  

  • 26. Communicating benefits and risks of screening for prostate, colon, and breast cancer.
    Barrett B; McKenna P
    Fam Med; 2011 Apr; 43(4):248-53. PubMed ID: 21499997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 28. New trial data do not end the PSA screening debate.
    Vastag B
    J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening.
    Smith RA; Andrews KS; Brooks D; Fedewa SA; Manassaram-Baptiste D; Saslow D; Brawley OW; Wender RC
    CA Cancer J Clin; 2017 Mar; 67(2):100-121. PubMed ID: 28170086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position.
    Helvie MA; Bevers TB
    J Natl Compr Canc Netw; 2018 Nov; 16(11):1398-1404. PubMed ID: 30442738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
    Zürcher S
    Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening for breast and prostate cancers: moving toward transparency.
    Newman DH
    J Natl Cancer Inst; 2010 Jul; 102(14):1008-11. PubMed ID: 20498425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summaries for patients. Screening smarter, not harder, for prostate cancer.
    Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
    [No Abstract]   [Full Text] [Related]  

  • 38. Off the mark: Current lung cancer screening guidelines miss those most at risk.
    Printz C
    Cancer; 2015 Aug; 121(15):2477-8. PubMed ID: 26198788
    [No Abstract]   [Full Text] [Related]  

  • 39. A risk-stratified approach to prostate-specific antigen screening.
    Keto CJ; Freedland SJ
    Eur Urol; 2011 Apr; 59(4):506-8. PubMed ID: 21292387
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
    Carroll PR; Whitson JM; Cooperberg MR
    J Clin Oncol; 2011 Feb; 29(4):345-7. PubMed ID: 21189396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.